|
| Brand Name: | LIBANG |
| Model Number: | USP |
| MOQ: | 30KG |
| Price: | negotiated |
| Payment Terms: | T/T, , L/C |
| Supply Ability: | 2 MT one month |
Sodium Diatrizoate
Diatrizoate, also known as amidotrizoate, is a contrast agent used during X-ray imaging. This includes visualizing veins, the urinary system, spleen, and joints, as well as computer tomography (CT scan). It is given by mouth, injection into a vein, injection into the bladder, through a nasogastric tube, or rectally.
Relatively common side effects include vomiting, diarrhea, and skin redness. Other side effects include itchiness, kidney problems, low blood pressure, and allergic reactions. It is not recommended in people who have an iodine allergy. Diatrizoate is an iodinated ionic radiocontrast agent with high osmolality.
Diatrizoate was approved for medical use in the United States in 1954. It is on the World Health Organization's List of Essential Medicines.
| TEST | SPECIFICATION | RESULT |
| Appearance | White, odorless powder | Conforms |
| Identification | (1) It responds to the Thin-Layer Chromatographic Identification Test | Conforms |
| (2) Positive reaction | Conforms | |
| Water | 4.5%~7.0% | 5.6% |
| Residue on ignition | NMT0.1% | 0.06% |
| Iodine and iodide | NMT 0.02% of iodide |
Conforms |
| Heavy metals | NMT 0.002% | Conforms |
| Free aromatic amine | NMT 0.05% | 0.008% |
| Ethyl alcohol | NMT 0.5% | Not detected |
| Acetic acid | NMT 0.5% | Not detected |
| Bacterial endotoxins | NMT 1.5 EU/g | ＜1.5 EU/g |
| Microbial Limit | Total aerobic microbial count: ＜1000 cfu/g | Conforms |
| Total yeast and molds count: ＜100 cfu/g | Conforms | |
| Assay | 98.0%～102.0%(Calculated on the anhydrous basis) | 99.2% |
Xi'an Libang is the first manufacture of Sodium Diatrizoate in China
Who we are:
XI’AN LIBANG PHARMACEUTICAL CO.,LTD. founded in 1996 with a location in Xi’an City of China, the center of the northwest pharmaceutical industry, is specialized in research, development, production and distribution of specialty pharmaceutical products. As the first and also largest supplier of generic Propofol in China, LIBANG started its business and subsequently launched a broad portfolio finished dosage forms covering s, cardiovascular, antineoplastic, clinical nutrition etc.
With more than 20 years growth, LIBANG has transformed into an integrated health care solution provider, LIBANG HEALTHCARE GROUP, with diversified fields covering high value-added APIs, pharmaceutical excipients, prescription drugs, OTC products, biomedicine, medical devices.
LIBANG is a technology-driven firm, with more than 8% of the annual sales revenues devoted to research and innovation, establishing a unique R&D platform to proactively follow the latest pharmaceutical technology frontier.
LIBANG now is one of Top 100 China’s Pharmaceutical Industries and also listed in the Top 20 The Most Potential Chinese Pharmaceuticals that was rated by the IMS Health.
